Enoxaparin-Induced Liver Injury

Shehriyar Mehershahi; Nikhitha Mantri; Aneesh Kumar; Shaikh Danial; Patel Harish

doi:10.1159/000508471

Enoxaparin-Induced Liver Injury

Case Rep Gastroenterol. 2020 Jun 10;14(2):315-319. doi: 10.1159/000508471. eCollection 2020 May-Aug.

Authors

Shehriyar Mehershahi^{1

2}, Nikhitha Mantri², Aneesh Kumar², Shaikh Danial^{1

2}, Patel Harish^{1

2}

Affiliations

¹ Department of Gastroenterology, Bronx Care Health System, Bronx, New York, USA.
² Department of Internal Medicine, Bronx Care Health System, Bronx, New York, USA.

Abstract

Enoxaparin, a form of low-molecular-weight heparin, can cause a rare, underreported, and often reversible form of hepatocellular injury. This report describes a case of enoxaparin-induced hepatotoxicity in a 61-year-old male diagnosed with pulmonary embolism. Elevations of liver enzymes were noted within 1 week of starting the drug, followed by a dramatic improvement upon its discontinuation, with subsequent normalization in the following days.

Keywords: Drug-induced liver injury; Enoxaparin; Non-alcoholic fatty liver disease; Viral hepatitis.

Publication types

Case Reports